Dr. Maria "Ken" Figueroa (IMAGE)
Caption
“These findings give us a new lens for understanding why some patients benefit from treatment,” said Maria “Ken” Figueroa, M.D. “That opens an opportunity to think more broadly about how we use epigenetic information to understand MDS and, eventually, to guide care.”
Credit
Sylvester Comprehensive Cancer Center
Usage Restrictions
Use with attribution
License
Original content